Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Exelixis (EXEL)

Exelixis Q3 revenue rises to $597.8 million; board authorizes $750 million buyback

Positive Impact 4 of 5 earnings Written later

Exelixis reported third-quarter 2025 total revenues of $597.8 million, up from $539.5 million a year earlier, and GAAP diluted earnings per share of $0.69, up from $0.40. The company raised the low end of its 2025 total revenue guidance and authorized a stock repurchase program of up to $750 million that runs through December 31, 2026.

Key points

  • Q3 2025 total revenues $597.8 million vs. $539.5 million in Q3 2024; net product revenues $542.9 million vs. $478.1 million
  • GAAP net income $193.6 million ($0.69 diluted EPS) vs. $118.0 million ($0.40) a year earlier; non-GAAP diluted EPS $0.78 vs. $0.47
  • 2025 total revenue guidance raised to $2.30 billion-$2.35 billion from $2.25 billion-$2.35 billion; R&D expense guidance lowered to $850 million-$900 million from $925 million-$975 million
  • Board authorized repurchase of up to $750 million of common stock before December 31, 2026; Q3 restructuring expenses were $19.8 million

The filing

CompanyExelixis (EXEL)
Form8-K, current report
Filed with the SECNov 4, 2025, 4:25 PM ET
Accession number0000939767-25-000127

Items reported: 2.02 Results of Operations8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:11 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 04, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.